Kinetics of phosphorolysis of 3-(β-D-ribofuranosyl)adenine and 3-(β-D-ribofuranosyl)hypoxanthine, non-conventional substrates of purine-nucleoside phosphorylase

European Journal of Biochemistry

Volumn 239, Issue 1, 1996, Pages 229-234

  Bzowska, Agnieszka ^a   Kulikowska, Ewa ^a   Poopeiko, Nicolai E ^b   Shugar, David ^a,c  

^a UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF BIOORGANIC CHEMISTRY   (Belarus)

^c INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

3 ( D ribofuranosyl)purine; Inhibitor; Kinetics; Purine nucleoside phosphorylase; Substrate

Indexed keywords

9 (2 FLUORO 3,4 DIHYDROXYBUTYL)GUANINE; ADENINE 3 RIBOSIDE; ADENINE DERIVATIVE; FORMYCIN; HYPOXANTHINE 3 RIBOSIDE; HYPOXANTHINE DERIVATIVE; PURINE NUCLEOSIDE PHOSPHORYLASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CATTLE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME KINETICS; ENZYME SUBSTRATE; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

ANIMALIA; BOS TAURUS; ESCHERICHIA COLI; MAMMALIA;

EID: 0030015116     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1996.0229u.x     Document Type: Article

References (41)

1. Giblett, E. R., Ammann, A. J., Wara, D. W., Sandman, R. & Diamond, L. K. (1975) Nucleoside phosphorylase deficiency in a child with severly defective T-cell immunity and normal B-cell immunity, Lancet 1, 1010-1013.
2. Ammann, A. J. (1978) Immunological aberrations in purine nucleoside deficiency, CIBA Found. Symp. 68, 55-75.
3. Stoeckler, J. D., Cambor, C., Kuhns, V., Chu, S.-H. & Parks, R. E. Jr (1982) Inhibitors of purine nucleoside phosphorylase C(8) and C(5′) substitutions, Biochem. Pharmacol. 31, 163-171.
4. Stoeckler, J. D., Ealick, S. E., Bugg, C. E. & Parks, R. E. Jr (1986) Design of purine nucleoside phosphorylase inhibitors, Fed. Proc. 45, 2773-2778.
5. Shewach, D. S., Chern, J.-W., Pillote, K. E., Townsend, L. B. & Daddona, P. E. (1986) Potentation of 2′-deoxyguanosine cytotoxicity by a novel inhibitor of purine nueleoside phosphorylase, 8-amino-9-benzyl-guanine, Cancer Res. 46, 519-523.
6. Bzowska, A., Kulikowska, H., Shugar, D., Bing-yi, C., Lindborg, B. & Johansson, N. G. (1991) Acyclonucleoside analogue inhibitors of mammalian purine nucleoside phosphorylase, Biochem. Pharmacol. 41, 1791-1803.
7. Dempcy, R. O. & Skibo, E. B. (1991) Rational design of quinazoline-based irreversible inhibitors of human erythrocyte purine nucleoside phosphorylase, Biochemistry 30, 8480-8487.
8. Ealick, S. E., Babu, Y. S., Narayana, S. V. L., Cook, W. J. & Bugg, C. E. (1990) Design of purine nucleoside phosphorylase inhbitors using X-ray crystallography, in Crystallographic and modelling methods in molecular design (Bugg, C. E. & Ealick, S. E., eds) pp. 43-55, Springer-Verlag. New York.
9. Gilbertsen, R. B., Josula, U., Sircar, J. C., Dong, M. K., Wu, W.-S., Wilbrun, D. J. & Conroy, M. C. (1992) Comparative in vitro and in vivo activities of two 9-deazaguanine analog inhibitors of purine nucleoside phosphorylase, Cl-972 and PD 141955, Biochem. Prarmacol, 44, 996-999.
10. Ealick, S. E., Babu, Y. S., Bugg, C. E., Erion, M. D., Guida, W. C., Montgomery, J. A. & Secrist, J. A. III (1991) Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors, Proc. Natl Acad. Sci. USA 88, 11540-11544.
11. Krenitsky, T. A., Tuttle, J. V., Miller, W. H., Moorman, A. R., Orr. G. F. & Beauchamp, L.(1990) Nucleotide analogue inhibitors of purine nucleoside phosphorylase, J. Biol. Chem. 265, 3066-3069.
12. Stoeckler, J. D. (1984) Purine nucleoside phosphorylase: a target for chemotherapy, in Develoments in cancer chemotherapy (Glazer, R. I., ed.) pp. 35-60, CRC Press Inc., Boca Raton.
13. Montgomery, J. A. (1993) Purine nucleoside phosphorylase: a target for drug design, Med. Res. Rev. 13, 209-228.
14. Bzowska, A., Kulikowska, E., Darzynkiewicz, E. & Shugar, D. (1988) Purine nucleoside phosphorylase: structure-activity relationships for substrate and inhibitor properties of N-1, N-7 and C-8-substituted analogues; differentiation of mammalian and bacterial enzymes with N-1 methylinosine and guanosine. J. Biol. Chem. 263, 9212-9217.
15. Bzowska, A., Kulikowska, E. & Shugar, D. (1993) Linear free energy relationships for N(7)-substituted guanosines as substrates of calf spleen purine nucleoside phosphorylse. Possible role of N(7)-protonation as an intermediary in phosphorolysis, Z. Naturforsch. Sect. C J. Biosci. 48, 803-811.
16. Ealick, S. E., Rule, S. A., Carter, D. C., Greenhough, T. J., Babu, Y. S., Cook, W. J., Habash, J., Halliwell, J. R., Stoeckler, J. D., Parks, R. E. Jr, Chen, S. F. & Bugg, C. E. (1990) Three-dimensional structure of human erythrocytic purine nucleoside phosphorylase at 3.2 Å resolution, J. Biol. Chem. 265, 1812-1820.
17. Porter, D. J. T. (1992) Purine nucleoside phosphorylase. Kinetic mechanism of the enzyine form calf spleen, J. Biol. Chem. 267, 7342-7351.
18. Kline, P. C. & Schramm, V. L. (1992) Purine nucleoside phosphorylase. Inosine hydrolysis, tight binding of the hypoxanthine intermediate, and third-the-sites reactivity, Biochemistry 31, 5964-5973.
19. Bzowska, A., Luic, M., Schroeder, W., Shugar, D., Saenger, W. & Koellner, G. (1995) Calf spleen purine nucleoside phosphorylase: purification, sequence and crystal structure of its complex with N(7)-acycloguanosine inhibitor. FEBS Lett. 367, 214-218.
20. Bzowska, A., Kulikowska, E. & Shugar, D. (1990) Properties of purine nucleoside phosphorylase (PNP) of mammalian and bacterial origin. Z. Naturforsch, Sect. C J. Biosci. 45, 59-70.
21. Bzowska, A., Kulikowska, E. & Shugar, D. (1992) Formyscins A and B and some analogues: selective inhibitors of bacterial (E. coli) purine nucleoside phosphorylase. Biochem. Biophys. Acta 1120, 239-247.
22. Bzowska, A. & Kazimierczuk, Z. (1995) 2-Chloro-2′-deoxyadenosine (cladribine) and its analogues are good substrates and potent selective inhbitors of Escherichia coli purine-nucleoside phosphorylase, Eur. J. Biochem. 233, 886-890.
23. Ehlhardt, W. J., Wheeler, W. J., Breau, A. P., Chay, S. H. & Birch. G. M. (1993) Biotransformation of the antiviral agent 1,3,4-thiazol-2-ylcyanamide (LY217896) and characteristics of a mesoionic ribose metabolite. Drug metab. dispas. 21, 162-170.
24. Kulikowska, E., Bzowska, A., Wierzchowski, J. & Shugar, D. (1986) Properties of two unusual, and fluorescent substrates of purine nucleoside phosphorylase: 7-methylguanosine and 7-methylinosine, Biochim. Biophys. Acta 874, 355-363.
25. Bzowska, A., Ananiev, A. V., Ramzaeva, N., Alksins, H., Maurins, J. A., Kulikowska, E. & Shugar, D. (1994) Purine nucleoside phosphorylase: inhibition by purine N(7)- and N(9)-acsclonucleosides; and substrate properties of 7-(β-D-ribofuranosyl)guanine and 7-(β-D-ribofuranosyl)hypoxanthine, Biochem. Pharinacol. 48, 937-947.
26. Doskocil, J. & Holy, A. (1977) Specificity of purine nucleoside phosphorylase from Escherichia Coli. Collect. Czech. Chem. Commun. 42, 370-383.
27. Lehikoinen, P. K., Sinnott, M. L. & Kremtsky, T. A. (1989) Investigation of α-deuterium isotope effects on the purine nucleoside phosphorylase reaction by the equilibrium-perturbation technique, Biochem. J. 257, 355-359.
28. Leonard, N. J. & Laursen, R. A. (1965) Synthesis of 3-(β-D-ribofuranosyl)adenine and 3-(β-D-ribofuranosyl)adenine-5′-phosphate. Biochemistry 4, 354-365.
29. Wolfenden, R., Sharpless, T. K., Ragande, I. S. & Leonard, N. J. (1966) Enzymatic and chemical deamination of 3-(β-D-ribofuranosyl)adenine, J. Am. Chem. Soc. 88, 185-186.
30. Elion, G. (1962) Condensed pyrimidine systems. XXII. N-methylpurines, J. Ory. Chem. 27, 2478 -2491.
31. Stoeckler, J. D., Agarwal, R. P., Agarwal, K. C. & Parks, R. E. Jr (1978) Purine nucleoside phosphorylase from human erythrocytes, Methods Enzynol. 51, 530-538.
32. Dawson, R. M. C., Elliott, D. C., Elliott, W. H. & Jones, K. M. (1969) Data for biochemical research, Oxford University Press, London.
33. Segal, I. H. (1975) Enzyme kinetics, John Wiley and Sons. New York.
34. Carlson, J. D. & Fischer, A. G. (1979) Thyroid purine nucleoside phosphorylase II. Kinetic model by alternate substrate and inhibition studies, Biochim. Biophys. Acta 566, 259-265.
35. Kline. P. C. & Schramm, V. L. (1993) Purine nucleoside phosphorylase: catalytic mechanism and transition state analysis of the arsenolysis reaction. Biochemistry 32, 13212-13219.
36. Zoltewicz, J. A., Clark, D. F., Sharpless, T. W. & Grahe, G. (1970) Kinetics and mechanism of the acid-catalyzed hydrolysis of some purine nucleosides. J. Am. Chem. Soc. 92, 1741-1750.
37. Leonard, N. J., Cruickshank, K. A., Groziak, M. P., Clauson, G. L. & Dewadas, B. (1986) Relatives of Watson-Crick DNA, RNA cross sections, Ann. N. Y. Acad. Sci. 471, 255-265.
38. Kumar, S., Wilson, S. R. & Leonard, N. J. (1988) Structure of 3-isoadenosine. Acta Crystallogr. C44, 508-510.
39. Shugar, D. & Psoda, A. (1990). Tautonierism of purines and pyrimidines, their nucleosides and various analogues, in Landolt-Bornstein Encyklopedie, vol. VII/Id. pp. 308-348. Springer-Verlag, Heidelberg.
40. Woo, P. W. K., Kostlan, C. R., Sircar, J. C., Dong, M. K. & Gilbertsen, R. B. (1992) Inhibitors of human purine nucleoside phosphorylase. Synthesis and biological activities of 8-amino-3-benzylhypoxanthine and related analogues, J. Med. Chem. 35, 1451-1457.
41. Bolduc, J. M., Dyer, D. H., Scott, W. G., Singer, P., Sweet, R. W., Koshland, D. K. & Stoddard, B. L. (1995) Mutagenesis and Laue structures of enzyme intermediates: isocitrate dehydrogenase, Science 268, 1312-1318.